Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
37,435,082
-
Number of holders
-
95
-
Total 13F shares, excl. options
-
25,875,011
-
Shares change
-
+183,111
-
Total reported value, excl. options
-
$287,157,179
-
Value change
-
+$3,096,368
-
Number of buys
-
40
-
Number of sells
-
-49
-
Price
-
$11.10
Significant Holders of LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) as of Q4 2021
108 filings reported holding LFCR - LIFECORE BIOMEDICAL, INC. DE - Common Stock as of Q4 2021.
LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) has 95 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 25,875,011 shares
of 37,435,082 outstanding shares and own 69.1% of the company stock.
Largest 10 shareholders include WYNNEFIELD CAPITAL INC (3,145,887 shares), Legion Partners Asset Management, LLC (2,928,090 shares), DIMENSIONAL FUND ADVISORS LP (1,973,608 shares), BlackRock Inc. (1,946,458 shares), ISZO CAPITAL MANAGEMENT LP (1,925,311 shares), Cove Street Capital, LLC (1,796,364 shares), VANGUARD GROUP INC (1,257,836 shares), HEARTLAND ADVISORS INC (1,224,615 shares), 22NW, LP (1,223,175 shares), and KENNEDY CAPITAL MANAGEMENT, INC. (704,722 shares).
This table shows the top 95 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.